Changes in Hong Kong stocks | Wangshan Wangshui-B (02630) rose more than 5% in the intraday period and received a voluntary extension of the ban period from all pre-IPO investors, including controlling shareholders

The Zhitong Finance App learned that Wangshan Wangshui-B (02630) rose more than 5% in the intraday period. As of press release, it had risen 3.45% to HK$78, with a turnover of HK$12.366 million.

According to the news, Wangshan Wangshui-B issued an announcement. Recently, the company received a notice from all pre-initial public sale investors, including controlling shareholders. According to this, based on high recognition of the value of the company's R&D pipeline, commercialization prospects of approved drugs, and the core management team, they each promised not to reduce their respective holdings of the company's shares in the company for 7 or 4 months from the expiration date of the original ban period until 7 or 4 months thereafter.

The Company believes that the extension of the sales ban period indicates that the aforementioned shareholders are confident in the future prospects and long-term value of the Company.